Natural history of multiple sclerosis: A unifying concept

Brain

Volumn 129, Issue 3, 2006, Pages 606-616

  Confavreux, Christian ^a   Vukusic, Sandra ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Age; Course; Multiple sclerosis; Natural history; Prognosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISABILITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION;

ADULT; AGE FACTORS; AGE OF ONSET; COHORT STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROGNOSIS;

EID: 33244466021     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awl007     Document Type: Article

References (56)

1. Amato MP, Ponziani G. A prospective study on the prognosis of multiple sclerosis. Neurol Sci 2000; 21 (Suppl): 831-8.
2. Andersson PB, Waubant E, Gee L, Goodkin DE. Multiple sclerosis that is progressive from the time of onset. Clinical characteristics and progression of disability. Arch Neurol 1999; 56: 1138-42.
3. Arnold DL. Magnetic resonance spectroscopy: imaging axonal damage in MS. J Neuroimmunol 1999; 98: 2-6.
4. Brex PA, Jenkins R, Fox NC, Crum WR, O'Riordan JL, Plant GT, et al. Detection of ventricular enlargement in patients at the earliest clinical stage of MS. Neurology 2000; 54: 1689-91.
5. Broman T, Andersen O, Bergmann L. Clinical studies on multiple sclerosis. I. Presentation of an incidence material from Gothenburg. Acta Neurol Scand 1981; 63: 6-33.
6. Ciccarelli O, Werring DJ, Wheeler-Kingshott CAM, Barker GJ, Parker GJ, Thompson AJ, et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001; 56: 926-33.
7. Confavreux C. L'histoire naturelle de la sclérose en plaques. Etude par informatique de 349 observations. Thèse de Médecine. Lyon: Université Claude Bernard; 1977. p. 184.
8. Confavreux C, Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 1980; 103: 281-300.
9. Confavreux C, Compston A. The natural history of multiple sclerosis. In: Compston A, editor. 'McAlpine's multiple Sclerosis. 4th edn.' London: Churchill Livingstone Elsevier; 2006. p. 183-272.
10. Confavreux C, Compston DAS, Hommes OR, McDonald WI, Thompson AJ. EDMUS, a European Database for Multiple Sclerosis. J Neurol Neurosurg Psychiatry 1992; 55: 671-6.
11. Confavreux C, Vukusic S. Natural History of Multiple Sclerosis: implications for counseling and therapy. Curr Opin Neurol 2002; 15: 257-66.
12. Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain 2006; 129: 595-605. First published January 16, 2006, doi:10.1093/brain/awh714.
13. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003; 126: 770-82.
14. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000; 343: 1430-8.
15. Cottrell DA, Kremenchutzky M, Rice GPA, Koopman WJ, Hader W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 1999; 122:625-39.
16. Coustans M, Leray E, Le Page E, Chaperon J, Edan G. Both relapsing-remitting and primary progressive multiple sclerosis are a two-stage disease, suggesting two consecutive mechanisms underlying the progression of disability in multiple sclerosis. Mult Scler 2004; 10 (Suppl): S111.
17. Eriksson M, Andersen O, Runmarker B. Long-term follow-up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler 2003; 9: 260-74.
18. Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000; 47: 391-5.
19. Filippi M, Campi A, Martinelli V, Pereira C, Scotti G, Comi G. Transitional progressive multiple sclerosis: MRI and MTI findings. Acta Neurol Scand 1995; 92: 178-82.
20. Filippi M, Bozzali M, Rovaris M, Gonen O, Kesavadas C, Ghezzi A, et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 2003; 126: 433-7.
21. Filippi M, Rovaris M, Inglese M, Barkhof F, De Stefano N, Smith S, et al. Interferon beta-1 a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Lancet 2004; 364: 1489-96.
22. Fog T, Linneman F. The course of multiple sclerosis in 73 cases with computer designed curves. Acta Neurol Scand Suppl 1970; 46 (Suppl 47): 3-175.
23. Fox NC, Jenkins R, Lary SM, Stevenson VL, Losseff NA, Crum WR, et al. Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology 2000; 54: 807-12.
24. Fu L, Matthews PM, De Stefano N, Worsley KJ, Narayanan S, Francis GS, et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 1998; 121: 103-13.
25. Gayou A, Brochet B, Dousset V. Transitional progressive multiple sclerosis: a clinical and imaging study. J Neurol Neurosurg Psychiatry 1997; 63: 396-8.
26. Ingle GT, Stevenson VL, Miller DH and Thompson AJ. Primary progressive multiple sclerosis: a 5-year clinical and MR study. Brain 2003; 126: 2528-36.
27. Kremenchutzky M, Cottrell D, Rice G, Hader W, Baskerville J, Koopman W, et al. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. Brain 1999; 122: 1941-9.
28. Kurtzke JF. On the evaluation of disability in multiple sclerosis. Neurology 1961; 11: 686-94.
29. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
30. Leibowitz U, Alter M. Multiple sclerosis: clues to its cause. Amsterdam: North-Holland Publishing Company; 1973. p. 1-373.
31. Losseff NA, Wang L, Lai HM, Yoo DS, Gawne-Cain ML, McDonald WI, et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 1996a; 119: 2009-19.
32. Losseff NA, Webb SL, O'Riordan JI, Page R, Wang L, Barker GJ, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996b; 119: 701-8.
33. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907-11.
34. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707-17.
35. McAlpine D, Compston ND. Some aspects of the natural history of disseminated sclerosis: incidence, course and prognosis; factors affecting onset and course. Q J Med 1952; 21: 135-67.
36. McDonnell GV, Hawkins SA. Primary progressive multiple sclerosis: a distinct syndrome? Mult scler 1996; 2: 137-41.
37. McDonnel GV, Hawkins SA. Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK. J Neurol Neurosurg Psychiatry 1998; 64: 451-4.
38. Minderhoud JM, Van der Hoeven JH, Prange AJA. Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study. Acta Neurol Scand 1988; 78: 10-5.
39. Myhr KM, Riise T, Vedeler C, Nortvedt MW, Gronning R, Midgard R, et al. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Multiple Sclerosis 2001; 7: 59-65.
40. Patzold U, Pocklington PR. Course of multiple sclerosis. First results of a prospective study carried out of 102 MS patients from 1976-1980. Acta Neurol Scand 1982; 65: 248-66.
41. Poser S. Multiple sclerosis. An analysis of 812 cases by means of electronic data processing. Berlin: Springer-Verlag; 1978.
42. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
43. Robertson NP, Clayton D, Fraser M, Deans J, Compston DA. Clinical concordance in sibling pairs with multiple sclerosis. Neurology 1996; 47: 347-52.
44. Rudick RA, Fischer E, Lee JC, Simon J, Jacobs L. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999; 53: 1698-704.
45. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993; 116: 117-34.
46. Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, et al. Problems of experimental trials of therapy in MS: report by the panel on the evaluation of experimental trials of therapy in MS. Ann N Y Acad Sci 1965; 122: 552-68.
47. Stevenson VL, Miller DH, Rovaris M, Barkhof F, Brochet B, Dousset V, et al. Primary and transitional progressive MS. A clinical and MRI crosssectional study. Neurology 1999; 52: 839-45.
48. Stevenson VL, Miller DH, Leary SM, Rovaris M, Barkhof F, Brochet B, et al. One year follow-up study of primary and transitional progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2000; 68: 713-8.
49. Thompson AJ, Kermode AG, Wicks D, MacManus DG, Kendall BE, Kingsley DP, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991; 29: 53-62.
50. Thompson AJ, Polman CH, Miller DH, McDonald WI, Brochet B, Filippi M, et al. Primary progressive multiple sclerosis. Brain 1997; 120: 1085-96.
51. Tortorella C, Viti B, Bozzali M, Sormani MP, Rizzo G, Gilardi MF, et al. A magnetization transfer histogram study of normal-appearing brain tissue in MS. Neurology 2000; 54: 186-93.
52. Traboulsee A, Dehmeshki J, Brex PA, Dalton CM, Chard D, Barker GJ, et al. Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS. Neurology 2002; 59: 126-8.
53. Vukusic S, Confavreux C. Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis. J Neurol Sci 2003; 206: 135-7.
54. Weinshenker BG. Progressive forms of MS: classification streamlined or consensus overtuned? Lancet 2000; 355: 162-3.
55. Weinshenker BG, Bulman D, Carriere W, Baskerville J, Ebers GC. A comparison of sporadic and familial multiple sclerosis. Neurology 1990; 40: 1354-8.
56. Youl BD, Turano G, Miller DH, Towell AD, MacManus DG, Moore SG, et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991; 114: 2437-50.